Hemex Health is organized around developing technologies to make affordable. life-sustaining medical care possible for people everywhere, no matter how underserved or remote their region. With backgrounds in international business and biomedical engineering, principals of the firm have extensive experience in this arena. The firm's two areas of business focus are global locations tackling elimination of for malaria, and those serving the large populations at risk for sickle cell in the developing world, where few in need are currently tested. In 2016, the firm secured exclusive licenses to technolgy developed by Case Western to develop and commercialize a pair of breakthrough technologies which promise to revolutionize the diagnosis of these two of the worlds most deadly diseases.
